Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection

An 81-year-old woman developed liver dysfunction after two months' treatment with direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection. She was positive for serum anti-nuclear antibody, with an elevated immunoglobulin G level. A liver biopsy revealed high-grade interfac...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Kotaro, Kikuchi, Kentaro, Kajiyama, Yusuke, Takano, Yuichi, Mabuchi, Masatoshi, Doi, Shinpei, Sato, Koichiro, Miyakawa, Hiroshi, Yasuda, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191578/
https://www.ncbi.nlm.nih.gov/pubmed/29709942
http://dx.doi.org/10.2169/internalmedicine.0613-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191578/
https://www.ncbi.nlm.nih.gov/pubmed/29709942
http://dx.doi.org/10.2169/internalmedicine.0613-17

Ejemplares similares